A viral or non-viral vector particle having a modified viral surface protein wherein the viral surface protein is modified to include a targeting polypeptide including a binding region which binds to an extracellular matrix component. Such vector particles are useful in delivering genes encoding therapeutic agents to cells located at the site of an exposed extracellular matrix component.

 
Web www.patentalert.com

< Method for end-to-end anastomosis

> Clinical indications for genotyping polymorphic variants of G-protein coupled receptors

~ 00423